Collaborations between product development partnerships and the World Health Organization

Bull World Health Organ. 2023 May 1;101(5):355-357. doi: 10.2471/BLT.22.289154. Epub 2023 Mar 31.

Authors

Matthias Helble¹, Tanja Kuchenmüller¹, John Reeder¹, Jerome H Kim², Bernard Pécoul³, David Reddy⁴, Mel Spigelman⁵, Soumya Swaminathan⁶

Affiliations

¹ Research for Health department, Science Division, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
² International Vaccine Institute, Seoul, Republic of Korea.
³ Drugs for Neglected Diseases initiative, Geneva, Switzerland.
⁴ Medicines for Malaria Venture, Geneva, Switzerland.
⁵ TB Alliance, New York, United States of America.
⁶ Science Division, World Health Organization, Switzerland.

No abstract available

MeSH terms

Drug Development*
Global Health*
Humans
International Cooperation*
Public-Private Sector Partnerships
Vaccine Development*
World Health Organization

Grants and funding

001/WHO_/World Health Organization/International